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R eperfusion hemorrhage of any degree occurs in ≤43% of patients after endovascular mechanical thrombectomy (EVT). 1 Although minor petechial hemorrhage may indicate successful recanalization, more severe parenchymal hemorrhage (PH) leads to worse outcomes. 1 Clinical and imaging biomarkers that predict symptomatic PH are necessary to identify at-risk patients and to develop new treatment strategies that minimize the risk of this complication.
Known imaging biomarkers of PH include large diffusion weighted imaging volume, 2 prolonged T max, 3 increased microvascular permeability, 4 and very low cerebral blood volume. 5 These biomarkers are derived from pre-and posttreatment magnetic resonance imaging (MRI) and computed tomographic (CT) examinations and many require image postprocessing that is not widely available. A biomarker of reperfusion PH present on digital subtraction angiography (DSA) would be extremely useful for rapidly identifying patients with acute ischemic stroke at risk of symptomatic PH without the need for postprocessing of other imaging data.
A prior study identified the presence of an early cerebral vein (ECV) during microcatheter angiography performed for intra-arterial thrombolysis with urokinase or tPA (tissue-type plasminogen activator) as a marker of subsequent reperfusion hemorrhage. 6 We have observed ECV after internal carotid artery DSA following modern EVT. To determine whether ECV is predictive of symptomatic PH after reperfusion, we Background and Purpose-Parenchymal hemorrhage (PH) after endovascular mechanical thrombectomy in acute ischemic stroke leads to worse outcomes. Better clinical and imaging biomarkers of symptomatic reperfusion PH are needed to identify patients at risk. We identified clinical and imaging predictors of reperfusion PH after endovascular mechanical thrombectomy with attention to early cerebral veins (ECVs) on postreperfusion digital subtraction angiography. Methods-We performed a retrospective cohort study of consecutive acute ischemic stroke patients undergoing endovascular mechanical thrombectomy at our neurovascular referral center. Clinical and imaging characteristics were collected from patient health records, and random forest variable importance measures were used to identify predictors of symptomatic PH. Predictors of secondary outcomes, including 90-day mortality, functional dependence (modified Rankin Scale score, >2), and National Institutes of Health Stroke Scale shift, were also determined. Diagnostic test characteristics of ECV for symptomatic PH were determined using a receiver operating characteristic analysis. Differences between patients with and without symptomatic PH were assessed with Fisher exact test and the Wilcoxon rank sum (Mann-Whitney U test) test at the 0.05 significance level. Results-Of 64 patients with anterior circulation large-vessel occlusion identified, 6 (9.4%) developed symptomatic PH.
ECV was the strongest predictor of symptomatic PH with more than twice the importance of the next best predictor, male sex. Although ECV was also predictive of 90-day mortality and functional dependence, other characteristics were more important than ECV for these outcomes. The sensitivity and specificity of ECV alone for subsequent hemorrhage were both 0.83, with an area under the curve of 0.83 and 95% confidence interval of 0.66 to 1.00. 
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Materials and Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Patient Cohort
Our Institutional Review Board approved this retrospective cohort study, which complied with the Health Insurance Portability and Accountability Act. Patient consent was waived by our review board. We identified consecutive patients with acute ischemic stroke who underwent EVT between January 2014 and March 2016. Inclusion criteria were patients who underwent EVT with (1) internal carotid artery terminus or M1 occlusion, (2) reperfusion score of Thrombolysis in Cerebral Infarction (TICI) I-III, and (3) brain CT or MRI after EVT. Exclusion criteria were patients with (1) posterior circulation stroke, (2) M2 or more distal occlusions, (3) no large-vessel occlusion on DSA, (4) TICI 0 reperfusion, (5) no post-treatment CT or MRI, or (6) missing clinical or imaging data required for statistical analysis. Patient clinical and outcome data were determined from electronic medical records.
Imaging
Detailed descriptions of the EVT procedure and imaging acquisition parameters are provided in the online-only Data Supplement. All DSA, CT, and MRI images were independently and blindly reviewed by 2 interventional neuroradiologists. ECV was defined as contrast opacification of a cerebral vein before the late arterial phase of the post-treatment DSA after internal carotid artery injection.
Follow-up CT and MRI studies were performed within 3 days of endovascular treatment. The presence of hemorrhage was noted on each study and graded as HI1, HI2, PH1, or PH2. 
Outcomes
The primary outcome measure was symptomatic PH (PH1 or PH2) with a decline from pretreatment National Institutes of Health Stroke Scale (NIHSS) score of at least 3 points. Secondary-outcome measures included (1) poor clinical outcome at 90 days of followup, defined as modified Rankin Scale (mRS) score of >2, (2) mortality at 90 days, and (3) change in the NIHSS from presentation to discharge (NIHSS shift). Patients with complete data for each outcome were analyzed.
Statistical Analysis
Detailed statistical methods that include the random forest analysis are presented in the online-only Data Supplement.
Results
We identified 112 patients who underwent EVT ( Figure I in the online-only Data Supplement). Forty-eight patients met exclusion criteria, which yielded 64 patients for the receiver operating characteristic analysis. Five additional patients were missing clinical data, so 59 patients were included in the random forest analysis for symptomatic PH and 90-day mortality. Seven additional patients were missing mRS scores at 90 days or NIHSS at discharge, so only 52 patients were included in the analysis of these outcomes.
In the receiver operating characteristic analysis, 6 patients developed symptomatic PH (PH+ group; 9.4%). A higher percentage of PH+ patients were male (83.3% versus 32.8% in the PH− group; P=0.02). There were no other significant differences between these groups (Table 1) .
PH+ patients were more likely to have ECV (83.3% versus 17.2% in PH− group; P<0.001; Table 2; Table I in the onlineonly Data Supplement; Figure III in the online-only Data Supplement; Movie I in the online-only Data Supplement). In the sensitivity analysis, we considered ECV to have occurred only if both readers observed ECV, and ECV occurred more frequently in PH+ patients than in PH− patients (83.3% PH+ to 6.9% PH−; P<0.001). The imaging and treatment characteristics of PH− and PH+ groups are summarized in Table 2 . PH+ patients had significantly higher 90-day mortality (83.3% versus 24.1%; P=0.01), but there were no differences with respect to 90-day mRS, discharge NIHSS, or NIHSS shift (Table II in the online-only Data Supplement).
In the primary outcome analysis, ECV was the best predictor of symptomatic PH after EVT, and ECV was more than twice as important as the next best predictor, male sex ( Figure  [A] ). Other characteristics that may be predictive included smoking status (prior smoker or unknown smoking status) and lower platelet count (Figure [A] ). Sensitivity analyses imposing a stricter condition for ECV occurrence (ie, both readers saw ECV) for all outcomes are presented in Figure IV in the online-only Data Supplement.
In the secondary-outcome analysis of 90-day mortality, lower platelet count was the best predictor, and older age was the second-best predictor (Figure [B] ). Other characteristics, such as normal cholesterol, lie close to the significance threshold, and their predictive utility is uncertain (Figure [B] ).
The most predictive characteristics of 90-day mRS >2 were NIHSS at admission and lower TICI score (Figure [C] ). Older age and ECV presence were also predictive but to a lesser degree (Figure [C] ).
The most important predictor of a higher NIHSS score at discharge than at admission was a lower TICI score. Hypertension may also be a predictive characteristic (Figure [D] ).
A receiver operating characteristic analysis found that ECV alone was highly predictive of symptomatic PH (area under the curve, 0.83; 95% confidence interval [CI], 0.66-1.00) with a sensitivity of 0.83 (95% CI, 0.5-1.0) and a specificity of 0.83 (95% CI, 0.72-0.91; Figure 
Discussion
ECV on postreperfusion DSA is a strong predictor of symptomatic PH and a moderate predictor of mortality and poor outcome (mRS>2) at 90 days. Early venous filling after stroke has been described, 6, 7 but the implications of this finding following modern EVT using mechanical and aspiration thrombectomy have not been established. Ohta et al 6 reported that ECV on superselective angiography before and during intraarterial thrombolysis may be an important marker of hemorrhagic complications. However, this study was confounded by the use of microcatheter injections and intra-arterial thrombolysis, which have been independently associated with reperfusion hemorrhage. 8, 9 By contrast, our study accounted for microcatheter injection using a statistically robust method, and our results are directly applicable to modern neurointerventional stroke practice.
ECV sensitivity (0.83) and specificity (0.83) compare favorably with noninvasive imaging biomarkers of reperfusion hemorrhage. 5, 10 Multiparametric approaches combining measures of very low cerebral blood volume and microvascular permeability have achieved specificities exceeding 0.83. 10 However, ECV is readily appreciated on routine postreperfusion DSA and has a high diagnostic accuracy without the need for image postprocessing.
Prior studies have also identified demographic and clinical variables, such as presentation NIHSS, antiplatelet medication use, and hyperglycemia, as predictors of reperfusion hemorrhage. 11 Our random forest variable importance measure accounted for both imaging and clinical variables as predictors of symptomatic hemorrhage, and ECV was more than twice as important as the next best predictor, male sex. These differences may reflect differences in populations, regional treatment biases, and the relatively small sample size.
The pathological basis of reperfusion hemorrhage is incompletely understood and is likely multifactorial. Cerebral ischemia induces changes in blood flow and breakdown of capillary integrity. Typically, ischemia initially results in regionally increased blood flow, sometimes termed 
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hyperemia or luxury perfusion. This change in blood flow may reflect capillary vasodilation secondary to loss of autoregulation 12 and cell death. We speculate that these changes are also the cause of ECV, which colocalizes with areas of infarction. 7 Sequelae of the initial ischemic injury and infarction in conjunction with effects of reperfusion can result in increased permeability of the blood-brain barrier and subsequent hemorrhage. 12 ECV may, therefore, identify tissue that is susceptible to bleeding.
Our results have implications for post-EVT clinical management. Emerging data suggest that increased blood pressure post-EVT correlates with poor clinical outcome, 13 and our results identify patients with ECV as a population in which aggressive blood pressure lowering may lead to reduced hemorrhage frequency. Additionally, the use of antiplatelet and anticoagulant therapies may also be informed by this study, in that patients who are known to be at a higher risk of hemorrhagic transformation may benefit from a longer delay to initiation of antiplatelet or anticoagulation therapy.
Limitations
This study is limited by selection bias because of the study occurring at a neurovascular referral center, retrospective design, and the inclusion of only internal carotid artery terminus and M1 segment occlusions. These biases may limit the generalizability of our findings. Additionally, there were only a small number of PH+ patients. A larger prospective or randomized study will be needed to confirm these results.
Conclusions
ECV on post-EVT DSA is highly predictive of subsequent symptomatic PH. The appearance of this finding has important implications for post-treatment blood pressure management and anticoagulation.
